Combination of post-operative radiotherapy and cetuximab for high-risk cutaneous squamous cell cancer of the head and neck: A propensity score analysis

Non-melanoma skin cancer is the most common human malignancy and the incidence of these cancers continues to rise [1]. Cutaneous squamous cell carcinomas (CSCC) make up approximately 20 –30% of all skin cancers. The incidence among elderly (>65  years) is approximately 4–8 times higher than younger persons. Although the vast majority of these cancers portend an excellent prognosis, some high risk CSSC may recur or metastasize [2]. The regional lymph nodes are the most common site of metastasis (85%) and despite aggressive therapy porte nds a dismal 5-year overall survival between 14 and 39% [3].

Source: Oral Oncology - January 31, 2018 Category: Cancer & Oncology Authors: Joshua D. Palmer, Charles J. Schneider, Neil Hockstein, Alexandra L. Hanlon, Jordan Silberg, Jon Strasser, Elizabeth A. Mauer, Michael Dzeda, Robert Witt, Adam Raben Source Type: research